LC
AERI

Lindbrook Capital’s Aerie Pharmaceuticals AERI Stock Holding History

Lindbrook Capital’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16
Closed – – 3070
2022
Q3 		$0 Sell
16
-16
-50% -$186 ﹤0.01% 3004
2022
Q2 		$0 Buy
+32
New +$226 ﹤0.01% 2867
2021
Q4 		– Sell
-387
Closed -$4K – 2243
2021
Q3 		$4K Sell
387
-109
-22% -$1.59K ﹤0.01% 1363
2021
Q2 		$8K Hold
496
– – ﹤0.01% 1165
2021
Q1 		$9K Hold
496
– – ﹤0.01% 1079
2020
Q4 		$7K Buy
496
+249
+101% +$3.01K ﹤0.01% 1089
2020
Q3 		$3K Buy
+247
New +$3.01K ﹤0.01% 1334

Lindbrook Capital's AERI Position: Q4 2022 in Review

Lindbrook Capital sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 16 shares.

Lindbrook Capital first reported a position in AERI in Q3 2020 and held it in 7 quarters. The position peaked at $9K in Q1 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Lindbrook Capital reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Lindbrook Capital sold 16 Aerie Pharmaceuticals shares in Q4 2022.
  • Lindbrook Capital first reported a position in Aerie Pharmaceuticals in Q3 2020 and held it in 7 quarters.
  • Lindbrook Capital's Aerie Pharmaceuticals position peaked at $9K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.